vimarsana.com
Home
Live Updates
Explorer Array Kit - Breaking News
Pages:
Page 2 - Explorer Array Kit News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Oxford BioDynamics Receives Reimbursement Code for EpiSwitch® Prostate Screening (PSE) Test
OXFORD, England (BUSINESS WIRE) Oct 3, 2023
United states
City of
United kingdom
Melanie toyne sewell rozi morris
Iain sexton
Paul stockdale
Jon burrows
Adam loudon jack kincade
Thomas guiel
Tanabe pharma
Oxford biodynamics plc
Laboratory developed test
American medical association
London stock exchange
Laboratory analysis code
Biodynamics plc
Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch® Prostate Screening Blood Test to Men With Prostate Cancer Risk
EpiSwitch Prostate Screening is designed to run alongside a standard PSA test PSE boosts PSA predictive accuracy from 55% to 94%1 for determining the presence or absence of prostate.
United states
City of
United kingdom
National library of medicine
Phillip pierorazio
Tanabe pharma
Jon burrows
American cancer society
Oxford biodynamics plc
Kallikrein panel
London stock exchange
Urology at penn presbyterian medical center
Hospital of university pennsylvania
Oxford biodynamics
Episwitch prostate screening
Prostate cancer awareness month
Investegate |Oxford BioDynamics Announcements | Oxford BioDynamics: Final Results
Investegate announcements from Oxford BioDynamics, Final Results
United states
United kingdom
City of
Paul stockdale
Melanie toyne sewell nathan billis
Jon burrows
Fiona conroy
Boston society applied biomarker analysis
Armistice capital master fund ltd
University of east anglia
Identification of the group
Senior management team
National cancer institute
Partnership for accelerating cancer therapies
Owners of the company
Group episwitch
vimarsana © 2020. All Rights Reserved.